張江高科(600895.SH):擬設立全資子公司集芯雲公司並進行在建工程資產劃轉
格隆匯3月5日丨張江高科(600895.SH)公佈,為盤活公司資產,提高經營管理效率,公司全資子公司----上海張江集成電路產業區開發有限公司擬投資設立上海集芯雲建築科技有限公司(暫定名,最終以市場監督管理部門核准名稱為準,簡稱:集芯雲公司),註冊資本人民幣56,013萬人民幣。
在集芯雲公司設立完成後,上海張江集成電路產業區開發有限公司擬以2024年3月31日為基準日,將上海集成電路設計產業園3-4項目在建工程資產及其對應負債按照賬面淨值劃轉至新成立的全資子公司,與劃轉項目相關的員工也根據相關政策一併轉入全資子公司。預計此次劃轉資產的賬面淨值不超過人民幣7億元,劃轉資產先用於認繳註冊資本,其餘作為企業資本公積。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.